OptiAge Level 1 and 2

OptiAge Levels 1 and 2 provide complete anti-aging support. OptiAge Level 1 provides the key nutrients needed for combating the effects of aging at the cellular level. Clinical research shows that having better vitamin D status is correlated with longer telomeres, which are a marker of biological aging.*

OptiAge Level 2 is a combination of cell-protecting and energizing ingredients important for optimal aging. PrimaVie is a Himalayan shilajit fulvic acid complex clinically shown to increase high-energy ATP levels in the body. Ubiquinol is a bioavailable reduced form of coenzyme Q10 that plays protective and energy metabolism roles in mitochondria of cells. R-alpha lipoic acid is the "Universal Antioxident" that works in virtually every tissue of the body and recycles other antioxidants.*
***** 5.0 Stars
Save 10% on this order & all future orders when you Upgrade To VIP AutoRefill
Learn More
With VIP AutoRefill you save 10% on this order and 10% on all future orders!
Learn More

OptiAge Level 1 and OptiAge Level 2 Package

OptiAge Level 1:
The four key ingredients to staying younger and healthier for longer
Creams and serums may reduce your visible aging.  But to really improve your longevity and health you need four essential ingredients:
1. Vitamin D3: Promotes longer telomeres.  Shorter telomeres are a marker of your biological aging.  In one study, Vitamin D was shown to reduce telomere aging equivalent to five years.*
2. Trans-resveratrol: Activates sirtuins – your anti-aging genes. Sirtuins are associated with greater lifespans in many organisms – in some cases up to 70%.  What's more, Trans-resveratrol is clinically documented to support your cardiovascular health, have an antioxidant effect, reduce inflammation and more.*
3. 5-methyltetrahydrofolate: Promotes healthy DNA methylation. Studies have shown better health where there is normal DNA methylation. 5-methyltetrahydrofolate helps keep your DNA – and you – healthy.*
4. Green tea leaf extract: Best known for its antioxidant properties, green tea leaf extract is recognized for maintaining overall health.* 
OptiAge Level 1 contains these four crucial ingredients to help fight the negative effects of aging at the cellular level.  Start improving your health and longevity today!*
And for the most complete anti-aging support available, be sure to use OptiAge Level 1 in conjunction with OptiAge Level 2.* See below for more information.

OptiAge Level 2:
The Himalayan secret for energetic aging

Are you using OptiAge Level 1 to stay younger and healthier for longer?*
But you need more energy?
Caffeine and guarana may give you a quick fix.  But there's a hidden price to pay …
Stimulants force your adrenal glands to pump out hormonal energy.  But do nothing to replace what you've used.  And one day you will run out.
For thousands of years, Ayurvedic medicine has been using Shilajit – a rare organic substance from the Himalayas.  It's rich in trace minerals, humic acid and fulvic acid.
Shilajit boosts your energy by increasing ATP levels – there's no adrenal robbery.  What's more, it also:
  • Provide antioxidant protection for mitochondria - your body’s cellular-energy powerhouses.*
  • Improves energy and increases performance during exercise.*
And it may help prevent the fine lines, wrinkles and sagging skin associated with aging by or turning on the genes responsible for collagen synthesis.*
Every OptiAge Level 2 capsule contains 200mg of this natural, energy-giving substance.*  But that's not all …
You also get 50mg of Ubiquinol – one of the most bioavailable (usable by the body) forms of CoQ10.  Found throughout your body it's an important anti-oxidant nutrient.*  It:
  • Supports healthy blood pressure, glucose and cholesterol levels.*
  • Improves your exercise performance, recovery times and VO2 max (a mark of how fit you are).*
  • Has anti-inflammatory effects.*
And – like Shilajit – supports your mitochondrial health.  In fact, they work in synergy, with Shilajit extending CoQ10's effects.*
Finally, OptiAge Level 2 contains 50mg of R-Alpha-Lipoic acid.  Known as the Universal Antioxidant, Alpha-Lipoic acid is effective throughout your body.  And it helps recycle all other antioxidants.
 So if you're using OptiAge Level 1 to stay younger and healthier for longer … and want more energy...*
 … why not give OptiAge Level 2 a try?
If you don't agree it's worth every cent of your purchase price, we'll give you your money back – no questions asked.


OptiAge Level 1 Ref.

  1. Abu El Maaty MA, Hanafi RSEl-Badawy SGad MZ. Aging Clin Exp Res. 2014 Aug;26(4):363-8.
  2. Almeida L, Vaz-da-Silva MFalcão ASoares ECosta RLoureiro AIFernandes-Lopes CRocha JFNunes TWright LSoares-da-Silva P. Mol Nutr Food Res. 2009 May;53 Suppl 1:S7-15. 
  3. Aloia JFLi-Ng M. Epidemiol Infect. 2007 Oct;135(7):1095-6; author reply 1097-8.
  4. Anderson JL, May HTHorne BDBair TLHall NLCarlquist JFLappé DLMuhlestein JBIntermountain Heart Collaborative (IHC) Study Group. Am J Cardiol. 2010 Oct 1;106(7):963-8.
  5. Anton SD, Embry C, Marsiske M, Lu X, Doss H, Leeuwenburgh C, Manini TM. Exp Gerontol. 2014 Sep;57:181-7.
  6. Armas LA, Hollis BWHeaney RP. J Clin Endocrinol Metab. 2004 Nov;89(11):5387-91.
  7. Assuncao M, Andrade JP. Front Biosci (Landmark Ed). 2015 Jan 1;20:247-62.
  8. Bass TM, Weinkove DHouthoofd KGems DPartridge L. Mech Ageing Dev. 2007 Oct;128(10):546-52.
  9. Basu A, Betts NMMulugeta ATong CNewman ELyons TJ. Nutr Res. 2013 Mar;33(3):180-7.
  10. Baur JA, Pearson KJPrice NLJamieson HALerin CKalra APrabhu VVAllard JSLopez-Lluch GLewis KPistell PJPoosala SBecker KGBoss OGwinn DWang MRamaswamy SFishbein KWSpencer RGLakatta EGLe Couteur DShaw RJNavas PPuigserver PIngram DKde Cabo RSinclair DA. Nature. 2006 Nov 16;444(7117):337-42.
  11. Bogdanski P, Suliburska JSzulinska MStepien MPupek-Musialik DJablecka A. Nutr Res. 2012 Jun;32(6):421-7. 
  12. Borras M, Panizo SSarró FValdivielso JMFernandez E. Clin Ther. 2012 Apr;34(4):849-56. 
  13. Brasnyó P, Molnár GAMohás MMarkó LLaczy BCseh JMikolás ESzijártó IAMérei AHalmai RMészáros LGSümegi BWittmann I. Br J Nutr. 2011 Aug;106(3):383-9.
  14. Brönstrup A, Hages MPrinz-Langenohl RPietrzik K. Am J Clin Nutr. 1998 Nov;68(5):1104-10.
  15. Bryan J, Calvaresi EHughes D. J Nutr. 2002 Jun;132(6):1345-56.
  16. Cao Y, Jones GCicuttini FWinzenberg TWluka ASharman JNguo KDing C. Trials. 2012 Aug 6;13:131. 
  17. Choi SW, Yeung VT, Collins AR, Benzie IF. Mutagenesis. 2015 Jan;30(1):129-37. 
  18. Crider KS, Yang TPBerry RJBailey LB. Adv Nutr. 2012 Jan;3(1):21-38.
  19. Dawson-Hughes B, Dallal GEKrall EAHarris SSokoll LJFalconer G. Ann Intern Med. 1991 Oct 1;115(7):505-12.
  20. Dawson-Hughes B, Harris SSKrall EADallal GE. N Engl J Med. 1997 Sep 4;337(10):670-6.
  21. Forman JP, Scott JBNg KDrake BFSuarez EGHayden DLBennett GGChandler PDHollis BWEmmons KMGiovannucci ELFuchs CSChan AT. Hypertension. 2013 Apr;61(4):779-85.
  22. Geusens P, Vanderschueren DVerstraeten ADequeker JDevos PBouillon R. Calcif Tissue Int. 1991 Sep;49(3):168-73.
  23. Ghanim H, Sia CLAbuaysheh SKorzeniewski KPatnaik PMarumganti AChaudhuri ADandona P. J Clin Endocrinol Metab. 2010 Sep;95(9):E1-8.
  24. Goh KP, Lee HYLau DPSupaat WChan YHKoh AF. Int J Sport Nutr Exerc Metab. 2014 Feb;24(1):2-13.
  25. Grazio S, Nagli?? ??BAni?? BGrubiši?? FBobek DBakula MKavanagh HSKuna ATCvijeti?? S. Am J Med Sci. 2015 Jan;349(1):46-9.
  26. Heaney RP, Barger-Lux MJDowell MSChen TCHolick MF. J Clin Endocrinol Metab. 1997 Dec;82(12):4111-6.
  27. Heaney RP, Dowell MSHale CABendich A. J Am Coll Nutr. 2003 Apr;22(2):142-6.
  28. Heaney RP, Recker RRGrote JHorst RLArmas LA. J Clin Endocrinol Metab. 2011 Mar;96(3): E447-52.
  29. Howitz KT, Bitterman KJCohen HYLamming DWLavu SWood JGZipkin REChung PKisielewski AZhang LLScherer BSinclair DA. Nature. 2003 Sep 11;425(6954):191-6. Epub 2003 Aug 24.
  30. Itami N, Shirasuna K, Kuwayama T, Iwata H. Theriogenology. 2015 May;83(8):1360-7.
  31. Kado DM, Karlamangla ASHuang MHTroen ARowe JWSelhub JSeeman TE. Am J Med. 2005 Feb;118(2):161-7.
  32. Kim YI. J Nutr. 2005 Nov;135(11):2703-9.
  33. Klaunig JE, Xu YHan CKamendulis LMChen JHeiser CGordon MSMohler ER 3rd. Proc Soc Exp Biol Med. 1999 Apr;220(4):249-54.
  34. Konstari S, Kaila-Kangas L, Jääskeläinen T, Heliövaara M, Rissanen H, Marniemi J, Knekt P, Arokoski J, Karppinen J. Rheumatology (Oxford). 2014 Oct;53(10):1778-82
  35. Laslett LL, Quinn SBurgess JRParameswaran VWinzenberg TMJones GDing C. Ann Rheum Dis. 2014 Apr;73(4):697-703.
  36. Li-Ng M, Aloia JFPollack SCunha BAMikhail MYeh JBerbari N. Epidemiol Infect. 2009 Oct;137(10):1396-404.
  37. Liu JJ, Prescott JGiovannucci EHankinson SERosner BHan JDe Vivo I. Am J Epidemiol. 2013 Jun 15;177(12):1411-7.
  38. Logan VF, Gray ARPeddie MCHarper MJHoughton LA. Br J Nutr. 2013 Mar 28;109(6):1082-8. 
  39. Magyar K, Halmosi RPalfi AFeher GCzopf LFulop ABattyany ISumegi BToth KSzabados E. Clin Hemorheol Microcirc. 2012;50(3):179-87.
  40. Malas FU, Kara MAktekin LErsöz MOzçakar L. Clin Rheumatol. 2014 Sep;33(9):1331-4. 
  41. Marcucci R, Zanazzi MBertoni ERosati AFedi SLenti MPrisco DCastellani SAbbate RSalvadori M. Transplantation. 2003 May 15;75(9):1551-5.
  42. Martins D, Wolf MPan DZadshir ATareen NThadhani RFelsenfeld ALevine BMehrotra RNorris K. Arch Intern Med. 2007 Jun 11;167(11):1159-65.
  43. McAlindon T, LaValley MSchneider ENuite MLee JYPrice LLLo GDawson-Hughes B. JAMA. 2013 Jan 9;309(2):155-62. 
  44. Murias M, Handler NErker TPleban KEcker GSaiko PSzekeres TJäger W. Bioorg Med Chem. 2004 Nov 1;12(21):5571-8.
  45. Pufulete M, Al-Ghnaniem RKhushal AAppleby PHarris NGout SEmery PWSanders TA. Gut. 2005 May;54(5):648-53.
  46. Richards JB, Valdes AMGardner JPPaximadas DKimura MNessa ALu XSurdulescu GLSwaminathan RSpector TDAviv A. Am J Clin Nutr. 2007 Nov;86(5):1420-5.
  47. Sanghi D, Mishra ASharma ACSingh ANatu SMAgarwal SSrivastava RN. Clin Orthop Relat Res. 2013 Nov;471(11):3556-62.
  48. Saposnik G, Ray JGSheridan PMcQueen MLonn EHeart Outcomes Prevention Evaluation 2 Investigators. Stroke. 2009 Apr;40(4):1365-72.
  49. Schnyder G, Roffi MFlammer YPin RHess OM. JAMA. 2002 Aug 28;288(8):973-9.
  50. Seijo M, Mastaglia SBrito GSomoza JOliveri B. Medicina (B Aires). 2012;72(3):195-200.
  51. Serafini M, Ghiselli AFerro-Luzzi A. Eur J Clin Nutr. 1996 Jan;50(1):28-32.
  52. Suliburska J, Bogdanski PSzulinska MStepien MPupek-Musialik DJablecka A. Biol Trace Elem Res. 2012 Dec;149(3):315-22. 
  53. Sun Q, Shi LRimm EBGiovannucci ELHu FBManson JERexrode KM. Am J Clin Nutr. 2011 Aug;94(2):534-42.
  54. Takada Y, Bhardwaj APotdar PAggarwal BB. Oncogene. 2004 Dec 9;23(57):9247-58.
  55. Timmers S, Konings EBilet LHoutkooper RHvan de Weijer TGoossens GHHoeks Jvan der Krieken SRyu DKersten SMoonen-Kornips EHesselink MKKunz ISchrauwen-Hinderling VBBlaak EEAuwerx JSchrauwen P. Cell Metab. 2011 Nov 2;14(5):612-22.
  56. Toole JF, Malinow MRChambless LESpence JDPettigrew LCHoward VJSides EGWang CHStampfer M. JAMA. 2004 Feb 4;291(5):565-75.
  57. Trang HM, Cole DERubin LAPierratos ASiu SVieth R. Am J Clin Nutr. 1998 Oct;68(4):854-8.
  58. Triantafyllou NI, Nikolaou CBoufidou FAngelopoulos ERentzos MKararizou EEvangelopoulos MEVassilopoulos D. Parkinsonism Relat Disord. 2008;14(4):321-5.
  59. Urashima M, Segawa TOkazaki MKurihara MWada YIda H. Am J Clin Nutr. 2010 May;91(5):1255-60.
  60. van der Griend R, Biesma DHHaas FJFaber JADuran MMeuwissen OJBanga JD. J Intern Med. 2000 Sep;248(3):223-9.
  61. van Oort FV, Melse-Boonstra ABrouwer IAClarke RWest CEKatan MBVerhoef P. Am J Clin Nutr. 2003 May;77(5):1318-23.
  62. Vermeulen EG, Stehouwer CDTwisk JWvan den Berg Mde Jong SCMackaay AJvan Campen CMVisser FCJakobs CABulterjis EJRauwerda JA. Lancet. 2000 Feb 12;355(9203):517-22.
  63. Warner AE, Arnspiger SA. J Clin Rheumatol. 2008 Feb;14(1):12-6.
  64. Weisburger JH. Proc Soc Exp Biol Med. 1999 Apr;220(4):271-5.
  65. Witham MD, Dove FJDryburgh MSugden JAMorris ADStruthers AD. Diabetologia. 2010 Oct;53(10):2112-9. 
  66. Wong RH, Howe PRBuckley JDCoates AMKunz IBerry NM. Nutr Metab Cardiovasc Dis. 2011 Nov;21(11):851-6.
  67. Wu SH, Ho SCZhong L. South Med J. 2010 Aug;103(8):729-37.
  68. Yajnik CS, Lubree HGThuse NVRamdas LVDeshpande SSDeshpande VUDeshpande JAUradey BSGanpule AANaik SSJoshi NPFarrant HRefsum H. Asia Pac J Clin Nutr. 2007;16(1):103-9.
  69. Yazaki Y, Chow GMattie M. J Altern Complement Med. 2006 Nov;12(9):881-5.
  70. Zhang FF, Driban JB, Lo GH, Price LL, Booth S, Eaton CB, Lu B, Nevitt M, Jackson B, Garganta C, Hochberg MC, Kwoh K, McAlindon TE. J Nutr. 2014 Dec;144(12):2002-8.
  71. Zhu H, Guo DLi KPedersen-White JStallmann-Jorgensen ISHuang YParikh SLiu KDong Y. Int J Obes (Lond). 2012 Jun;36(6):805-9.
OptiAge Level 2 Ref.
  1. Bresolin N, Doriguzzi CPonzetto CAngelini CMoroni ICastelli ECossutta EBinda AGallanti AGabellini S, et al. J Neurol Sci. 1990 Dec;100(1-2):70-8.
  2. Digiesi V, Cantini FOradei ABisi GGuarino GCBrocchi ABellandi FMancini MLittarru GP. Mol Aspects Med. 1994;15 Suppl:s257-63.
  3. Sobreira C, Hirano MShanske SKeller RKHaller RGDavidson ESantorelli FMMiranda AFBonilla EMojon DSBarreira AAKing MPDiMauro S. Neurology. 1997 May;48(5):1238-43.
  4. Ylikoski T, Piirainen JHanninen OPenttinen J. Mol Aspects Med. 1997;18 Suppl: S283-90.
  5. Thibault A, Samid DTompkins ACFigg WDCooper MRHohl RJTrepel JLiang BPatronas NVenzon DJReed EMyers CE. Clin Cancer Res. 1996 Mar;2(3):483-91.
  6. Breithaupt-Grögler K, Niebch GSchneider EErb KHermann RBlume HHSchug BSBelz GG. Eur J Pharm Sci. 1999 Apr;8(1):57-65.
  7. Singh RB, Niaz MARastogi SSShukla PKThakur AS. J Hum Hypertens. 1999 Mar;13(3):203-8.
  8. Konrad T, Vicini PKusterer KHöflich AAssadkhani ABöhles HJSewell ATritschler HJCobelli CUsadel KH. Diabetes Care. 1999 Feb;22(2):280-7.
  9. Jacob S, Ruus PHermann RTritschler HJMaerker ERenn WAugustin HJDietze GJRett K. Free Radic Biol Med. 1999 Aug;27(3-4):309-14.
  10. Bonetti A, Solito FCarmosino GBargossi AMFiorella PL. J Sports Med Phys Fitness. 2000 Mar;40(1):51-7.
  11. Kaikkonen J, Tuomainen TPNyyssonen KSalonen JT. Free Radic Res. 2002 Apr;36(4):389-97.
  12. Hodgson JM, Watts GFPlayford DABurke VCroft KD. Eur J Clin Nutr. 2002 Nov;56(11):1137-42.
  13. Hosoe K, Kitano MKishida HKubo HFujii KKitahara M. Regul Toxicol Pharmacol. 2007 Feb;47(1):19-28.
  14. Biswas TK, Pandit SMondal SBiswas SKJana UGhosh TTripathi PCDebnath PKAuddy RGAuddy B. Andrologia. 2010 Feb;42(1):48-56.
  15. Porasuphatana S, Suddee SNartnampong AKonsil JHarnwong BSantaweesuk A. Asia Pac J Clin Nutr. 2012;21(1):12-21.
  16. Keith DJ, Butler JABemer BDixon BJohnson SGarrard MSudakin DLChristensen JMPereira CHagen TM. Pharmacol Res. 2012 Sep;66(3):199-206.
  17. Muraki A, Miyashita KMitsuishi MTamaki MTanaka KItoh H. J Appl Physiol (1985). 2012 Aug;113(3):479-86.
  18. Failla ML, Chitchumroonchokchai CAoki F. J Agric Food Chem. 2014 Jul 23;62(29):7174-82.
  19. Stohs SJ. Phytother Res. 2014 Apr;28(4):475-9.
  20. Packer L, Witt EHTritschler HJ. Free Radic Biol Med. 1995 Aug;19(2):227-50.
  21. Biewenga GP, Haenen GRBast A. Gen Pharmacol. 1997 Sep;29(3):315-31.
  22. Burke BE, Neuenschwander ROlson RD. South Med J. 2001 Nov;94(11):1112-7.
  23. Caso G, Kelly PMcNurlan MALawson WE. Am J Cardiol. 2007 May 15;99(10):1409-12.
  24. Kumar MR, Reddy AGAnjaneyulu YReddy GD. Toxicol Int. 2010 Jul;17(2):45-8. 
  25. Ansar H, Mazloom ZKazemi FHejazi N. Saudi Med J. 2011 Jun;32(6):584-8.
  26. Hermann R, Mungo J, Cnota PJ, Ziegler D. Clin Pharmacol. 2014 Nov 28;6:195-204.